IGM Biosciences Cash from Financing (TTM) Insights

IGM Biosciences Inc (IGMS)

9.40 +1.75 (+22.88%) USD | NASDAQ | Apr 26, 16:00

9.41 +0.01 (+0.11%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	115.07M
September 30, 2023	115.15M
June 30, 2023	70.81M
March 31, 2023	219.38M
December 31, 2022	219.38M
September 30, 2022	220.39M
June 30, 2022	221.16M
March 31, 2022	2.601M
December 31, 2021	2.476M

Date	Value
September 30, 2021	216.90M
June 30, 2021	214.91M
March 31, 2021	214.71M
December 31, 2020	214.78M
September 30, 2020	-3.123M
June 30, 2020	222.44M
March 31, 2020	272.25M
December 31, 2019	282.26M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-3.123M

Minimum

Sep 2020

282.26M

Maximum

Dec 2019

165.97M

Average

214.91M

Median

Jun 2021

Cash from Financing (TTM) Benchmarks